Cardinal Health (NYSE:CAH) is facing multiple ongoing Class I recalls of Presource PBDS kits that contain BD Alaris Pump Infusion Sets due to reported performance issues. The affected recalls, classified by regulators as the most serious tier, cover thousands of procedure kits used in hospital settings. Regulators state that Class I actions reflect a possibility of significant health consequences if the recalled infusion components are used in patients. These Class I recalls of Presource...
Detailed price information for Lockheed Martin Corp (LMT-N) from The Globe and Mail including charting and trades.
Cardinal Health has turned into one of the stronger long term performers in the healthcare distribution space. This puts fresh attention on whether the current share price lines up with what its earnings can support. After such a strong run, the key issue for you is whether the recent optimism baked into the stock is covered by the profit engine underneath. Over the past 5 years, Cardinal Health has delivered a very large cumulative return. This now makes the earnings power of the business...
We just published the list of Jim Cramer’s Top 10 Dividend Stocks for Safe, Consistent Returns, and Cardinal Health, Inc. (NYSE:CAH) ranked 9th on this list. From 2000 through 2009, dividends earned S&P 500 investors an annualized 1.8%, according to Hartford Funds. Even with those payments, the index posted a negative total return for the […]
Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.
Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.
Cardinal Health reported first quarter fiscal 2027 results for the period ended September 30, 2026, with sales of US$67.513b, net income of US$554m, and diluted EPS from continuing operations of US$2.38 compared with US$1.88 a year earlier. The company lifted its full year adjusted EPS guidance after outperformance in Pharmaceutical and Specialty Solutions, underlining management’s focus on higher value distribution and services across specialty, biopharma partnerships, and at home care. We...
Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.
The drug distributor also raised its full-year earnings guidance.
Cardinal Health stock rose deeper into a buy zone Thursday on a solid third-quarter report and guidance hike.
Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.
Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.
Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cardinal (CAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
This is the newest page. Registered accounts read further back.